Sleep Quality
Synopsis
Sleep Quality: A Nutrition and Natural-Health Reference
1. Definition and Conceptual Framework
Sleep quality is defined as an individual's self-satisfaction with all aspects of the sleep experience, and it encompasses four core attributes: sleep efficiency, sleep latency, sleep duration, and wake after sleep onset. The concept is multidimensional, and its measurement has been standardised through validated instruments. Sleep quality is most widely assessed using the Pittsburgh Sleep Quality Index (PSQI), which encompasses seven components of self-reported sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
Although sleep quality has been measured using different strategies, from physiological responses to a single-item self-report question, there is some consensus that it encompasses several complementary aspects such as sleep duration, latency, efficiency, degree of fragmentation, total wake time, sleep disruptive events and daytime dysfunction, among others.
Sleep quality has both a subjective and an objective dimension. The "quality of sleep" may be evaluated from an objective and a subjective point of view. Objective sleep quality refers to how difficult it is for a person to fall asleep and remain in a sleeping state, and how many times they wake up during a single night. Subjective sleep quality refers to a sense of being rested and regenerated after awaking from sleep. A preliminary definition of sleep quality should include reference to tiredness on waking and throughout the day, feeling rested and restored on waking, and the number of awakenings in the night.
2. Body Systems Involved
2.1 The Nervous System and Sleep Architecture
Healthy sleep is a fundamental pillar of various neurophysiological, emotional, and cognitive processes, including emotion regulation, memory consolidation, and brain waste clearance. Physiological sleep consists of two main phases—the REM (rapid eye movements) phase and the NREM (non-REM) phase—which are repeated during sleep. The REM phase is associated with the activation of the sympathetic nervous system, and it leads to an increase in temperature and blood pressure and to an accelerated heart rate. During the REM sleep phase, there is also a decrease in muscle tone and activation in the limbic regions, which suggests that REM plays a role in emotional regulation.
The most restful sleep occurs during stages 3 and 4 NREM sleep, and one indicator of sleep quality is the percentage of time a patient spends in these sleep stages. Neurotransmitters involved in promoting wakefulness include acetylcholine, dopamine, glutamate, histamine, norepinephrine, orexin, and serotonin. The inhibitory neurotransmitter GABA plays a contrasting, sleep-promoting role: GABA, the principal inhibitory neurotransmitter in the central nervous system, not only suppresses neuronal excitability to promote sleep but also interacts with circadian clock genes to modulate sleep–wake rhythms.
Adenosine is an endogenous sleep-producing substance. A breakdown product of adenosine triphosphate (ATP), adenosine is believed to be a homeostatic sleep factor that mediates the transition from prolonged wakefulness to NREM sleep. Adenosine mediates this transition by inhibiting arousal-promoting neurons of the basal forebrain.
2.2 The Circadian System
The regulation of sleep is processed by the homeostatic physiology of the circadian rhythm, the sleep/wake cycle. Circadian rhythm is the 24-hour internal clock in our brain that regulates cycles of alertness and sleepiness by responding to light changes in our environment. The regulation of sleep in humans is governed by processes influenced by hormonal and environmental factors, including a daily sleep-wake cycle influenced by a circadian rhythm tied to light-dark cycles controlled by a cluster of about 10,000 neurons located in the hypothalamus behind the eyes, called the suprachiasmatic nuclei (SCN).
Clock genes regulate neurotransmitter systems (e.g., melatonin, serotonin, GABA, dopamine), mitochondrial function, and neuroimmune crosstalk, offering a molecular framework to explain sleep fragmentation and impaired sleep quality. Sleep continuity or sleep consolidation is an important determinant of sleep quality. The circadian process has a strong impact on this characteristic of sleep, such that the duration of awakenings is much shorter during the biological night than during the biological day.
2.3 The Endocrine and Immune Systems
During sleep, most of the body's systems are in an anabolic state, helping to restore the immune, nervous, skeletal, and muscular systems; which are vital processes that maintain mood, memory, and cognitive function and play a large role in the function of the endocrine and immune systems. During sleep, there is a decrease in the release of cortisol, norepinephrine, and adrenaline. The concentration of hormones that affect cell growth, such as growth hormones, melatonin, and prolactin, increases. Prolactin and growth hormone influence the differentiation and formation of new T cells and stimulate the function of type 1 cytokines that control the antigenic response of lymphocytes.
Two effector systems are responsible for regulating the immune response—the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis—which are both influenced by sleep. When you sleep too little, the immune system produces a reduced number of antibodies, which are involved in the body's defensive reactions.
Cortisol shows a clear circadian pattern, with the peak occurring just before waking in diurnal animals such as humans. Circadian rhythms and sleep are fundamental biological processes integral to human health, and their disruption is associated with detrimental physiological consequences, including cognitive, metabolic, cardiovascular, and immunological dysfunctions.
3. Contributing and Associated Factors
3.1 Physiological Factors
Antecedents to sleep quality include physiological factors such as age, circadian rhythm, body mass index, NREM, and REM; psychological factors such as stress, anxiety, and depression; and environmental factors such as room temperature, television/device use, and family/social commitments.
Disruption of circadian rhythms and sleep is associated with detrimental physiological consequences, including cognitive, metabolic, cardiovascular, and immunological dysfunctions. Poor sleep health is a growing public health concern given that both short and poor sleep are consistently linked with heightened risk for cardiometabolic diseases, including obesity, type 2 diabetes, and cardiovascular disease.
3.2 Psychological and Environmental Factors
Stress, anxiety, and depression are among the most documented psychological antecedents to poor sleep quality. Physiological conditions associated with sleep quality may be organised into conditions of the cardiovascular, respiratory, muscle, and nervous systems, and conditions relating to blood chemistry. Environmental conditions may be broadly defined to include the environmental surroundings affecting the patient, such as ambient light, temperature, humidity, air pollution, noise, and barometric pressure.
3.3 Genetic Factors
Given the moderate heritability of circadian and sleep traits, genetics offers an opportunity that complements insights from model organism studies to advance fundamental molecular understanding of human circadian and sleep physiology and linked chronic disease biology.
4. Nutrients Studied in Relation to Sleep Quality
4.1 Tryptophan
Tryptophan is an essential amino acid that serves as the dietary precursor to serotonin and, downstream, to melatonin. Tryptophan, specifically its ratio relative to large neutral amino acids (LNAA) in the blood, appears to be a potential mediator of diet's effect on sleep. Tryptophan is a precursor of the synthesis of the serotonin neurotransmitter and melatonin hormone, which are both integral to sleep-wake regulation. Researchers have proposed that diets that increase the Trp:LNAA ratio allow for greater synthesis of these sleep-promoting factors. When Trp levels are increased, the amino acid can surpass other LNAA for transport across the blood-brain barrier. Once across, Trp is converted to serotonin, which in turn regulates sleep-wake.
Tryptophan is necessary for serotonin synthesis, and tryptophan depletion leads to sleep disturbances through the serotonergic pathway. Significant decreases in total sleep time, longer sleep onset latency, and reduced sleep efficiency occur after tryptophan restriction. Tryptophan deficiency is also associated with increased wake periods. Hence, consumption of tryptophan-rich food items like cereals and high-protein diets containing tryptophan can assist in improving sleep outcomes.
Evidence strength: A meta-analysis of 28 RCTs found that tryptophan, vitamin D, omega-3, zinc, and antioxidants may enhance sleep quality by decreasing sleep latency and wake after sleep onset, increasing sleep efficiency, and extending total sleep time. Evidence is primarily mechanistic and observational; well-powered, dedicated tryptophan supplementation trials in sleep-disordered populations are limited.
4.2 Melatonin
Melatonin is both a hormone synthesized endogenously in the pineal gland and a compound found in small amounts in various foods. Melatonin is a physiological indoleamine involved in circadian rhythm regulation and is currently used for secondary sleep disorders supported by empirical evidence.
Scientific evidence: A systematic review and meta-analysis was conducted to review the effect of melatonin on sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) in adults with various diseases, summarizing evidence from randomized clinical trials. Of 2,642 papers screened, 23 RCTs met inclusion criteria. Results indicated that melatonin had a significant effect on sleep quality as assessed by the PSQI (WMD: −1.24; 95% CI −1.77 to −0.71; p = 0.000).
A meta-analysis including a total of 34 RCTs (21 in children/adolescents: N = 984; 13 in adults: N = 1,014) found evidence that melatonin significantly improved sleep onset latency and total sleep time, but not sleep awakenings, in children and adolescents with a variety of neurodevelopmental disorders, and sleep onset latency as well as total sleep time in adults with delayed sleep phase disorder.
Pooled data demonstrate that exogenous melatonin lowers sleep onset latency and increases total sleep time, whereas it has little if any effect on sleep efficiency. A large scoping review of systematic reviews found that despite heterogeneity in review methods and outcome definitions, the direction of evidence consistently favored melatonin over placebo. According to GRADE methodology, weak recommendations were made for preventing phase shifts from jet lag, for improving insomnia in both healthy volunteers and individuals with a history of insomnia, and for initiating sleep and/or improving sleep efficacy.
4.3 Magnesium
Magnesium is an essential mineral involved in hundreds of enzymatic reactions and is of particular interest in sleep research because of its role in GABA receptor function and regulation of the HPA axis.
Scientific evidence: A study using 500 mg of daily magnesium supplementation showed improvements in sleep efficiency, sleep duration, sleep onset latency, and early-morning awakening frequency compared to placebo. A recent systematic review, encompassing 7,582 participants from 9 published cross-sectional, cohort, and randomized controlled studies, identified an association between magnesium status and sleep quality. The findings demonstrated that in healthy adults, higher magnesium intake was correlated with various sleep quality parameters, including daytime sleepiness, drowsiness, snoring, and sleep duration. Randomized controlled trials recorded positive impacts of magnesium supplementation on PSQI scores, sleep efficiency, and sleep duration.
A recent well-powered RCT found that a randomized, double-blind, placebo-controlled trial enrolled 155 adults aged 18–65 years with self-reported poor sleep quality. Participants were assigned to either magnesium bisglycinate (250 mg elemental magnesium daily) or placebo. The magnesium bisglycinate group showed a significantly greater reduction in Insomnia Severity Index (ISI) scores compared to the placebo group from baseline to week 4 (−3.9 vs −2.3; p = 0.049).
A recent systematic review concluded that while observational studies suggest an association between magnesium status and sleep quality, interventional trials have yielded inconsistent results, highlighting the need for well-designed studies with larger sample sizes and longer durations. However, growing evidence supports the role of magnesium supplementation in improving sleep outcomes. Magnesium has been implicated to benefit sleep, although clinical evidence varied based on the magnesium source used. Magnesium L-threonate is a promising form due to its brain bioavailability and effects on cognition, memory, and mood. Evidence strength: Preliminary to moderate; results are promising but heterogeneous across form, dose, and population.
4.4 Vitamin D
Clinical implications suggest that vitamin D supplementation may be a valuable adjunctive approach to managing sleep disorders. A dose of 50,000 IU bi-weekly for eight weeks proved effective in one study, though individual variations and underlying health conditions should be considered. Given the prevalence of vitamin D deficiency in various populations, optimizing vitamin D status could be a simple and cost-effective strategy to improve sleep quality. Evidence strength: Limited; further well-controlled studies are required.
4.5 Omega-3 Fatty Acids
Total sleep time as measured by actigraphy was negatively associated with intake of total fat and saturated fat. From limited studies, it seems that the consumption of saturated fatty acids deteriorates sleeping wellness. Conversely, omega-3 polyunsaturated fatty acids (PUFAs) have been associated with improved sleep. A high intake of fish and vegetables has a positive effect on sleep, and fatty fish is rich in vitamin D and omega-3 fatty acids.
The current body of literature converges to suggest that omega-3 fatty acids subjectively and objectively improve several sleep-related parameters and outcomes in young, older, and clinical cohorts. Evidence strength: Modest, primarily from observational studies; clinical trial data are limited but directionally positive.
4.6 L-Theanine
L-theanine, an amino acid primarily found in green tea, has gained attention for its potential impact on sleep due to its calming properties. The proposed mechanism for L-theanine's influence on sleep lies in its ability to modulate neurotransmitters. L-theanine readily crosses the blood-brain barrier and is known to increase the production of GABA.
In study outcomes, administration of L-theanine resulted in substantial decreases in stress-related symptoms and notable enhancements in cognitive function compared to placebo. L-theanine seems to present promising sleep-promoting properties. Evidence strength: Preliminary; current human trial data are limited in number and scale.
4.7 Glycine
Glycine seems to present promising sleep-promoting properties. Glycine is a non-essential amino acid proposed to improve sleep quality through peripheral vasodilatory effects that facilitate core body temperature reduction, a physiological precondition for sleep onset. Evidence strength: Very preliminary; trial data are limited to small studies, and larger well-controlled trials are needed.
5. Herbs and Natural Ingredients: Traditional Use and Scientific Evidence
5.1 Valerian Root (Valeriana officinalis L.)
Traditional Use
Over centuries, valerian root has been utilized to alleviate insomnia, nervousness, and restlessness, and it remains one of the most widely used herbal sleep aids in modern phytotherapy. Historically recommended as a sedative since the second century, valerian has gained popularity as a natural remedy in both Europe and the United States. The root of the valerian plant is the part used for medicinal purposes, commonly consumed as dried herb, extract, or in tea form.
Proposed Mechanisms
Pharmacological studies suggest that valerian may exert its effects through multiple neuromodulatory pathways, including interactions with the adenosine, serotonin, and GABAergic systems. Valerian roots and rhizomes contain a complex mixture of bioactive compounds such as monoterpenes, sesquiterpenes, flavonoids, caffeic acids, and lignans. Collectively, these compounds contribute to the multifaceted pharmacological effects of valerian, supporting its traditional use in alleviating sleep disorders. Research suggests that valerian might influence GABA levels, akin to conventional tranquilizers, yet the exact mechanisms remain unclear.
Scientific Evidence
PubMed, ScienceDirect, and Cochrane Library were searched in a systematic review and meta-analysis. A total of 60 studies (n = 6,894) were included, and meta-analyses were performed to evaluate the effectiveness to improve subjective sleep quality (10 studies, n = 1,065) and to reduce anxiety (8 studies, n = 535). Valerian is a popular herbal medicine used as a sleep aid; however, the outcomes of previous clinical studies are inconsistent.
Evidence from clinical studies of the efficacy of valerian in treating sleep disorders such as insomnia is inconclusive. Constituents of valerian have been shown to have sedative effects in animals, but there is no scientific agreement on valerian's mechanisms of action. A systematic review concluded that, although valerian is a safe herb, evidence did not support the clinical efficacy of valerian as a sleep aid for insomnia. Popular herbal remedies with a long-standing history of traditional medicinal use, namely valerian root extracts, lack adequate support to justify their use in individuals experiencing sleep disorders.
Evidence strength: Overall weak and inconsistent in human trials; animal and in vitro studies suggest sedative activity but human RCT findings remain mixed. The NIH Office of Dietary Supplements characterises the clinical evidence as inconclusive.
5.2 Ashwagandha (Withania somnifera L.)
Traditional Use
Ashwagandha (Withania somnifera), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress and improving memory. In classical Ayurvedic texts, the root was used as a rasayana (rejuvenating tonic) to improve energy, vitality, and sleep quality in the elderly, and was traditionally prepared as a milk decoction.
Scientific Evidence
A double-blind, randomized, placebo-controlled clinical study evaluated the effect of ashwagandha root extract (300 mg sustained-release capsule) on cognitive functions, stress levels, sleep quality, and overall well-being in 130 healthy, cognitively sound stressed adults aged 20–55 years, who took one capsule daily for 90 consecutive days. Treatment improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.
In a study of elderly participants, statistically significant improvement was observed in the ashwagandha treatment group compared to placebo, and a significant increase in the quality of sleep (p < 0.0001) and mental alertness (p < 0.034) was observed compared to the placebo group.
Ashwagandha may be considered a subsidiary sleep aid by working in synergy with other soporific nutrients or by addressing concomitant physiological mechanisms that may disrupt healthy sleep–wake patterns by indirect routes. Evidence strength: Preliminary to moderate; studies are limited in number and mostly use proprietary extracts; beneficial effects appear linked to stress reduction rather than direct hypnotic activity.
5.3 Chamomile (Matricaria chamomilla) and Apigenin
Chamomile (Matricaria chamomilla and Chamaemelum nobile) has been used in European and Middle Eastern traditions for centuries as an infusion to relieve nervousness and promote sleep. The primary bioactive flavone is apigenin, which is proposed to act as a partial agonist at benzodiazepine receptors. The current body of literature converges to suggest that apigenin-containing chamomile subjectively and objectively improves several sleep-related parameters and outcomes in young, older, and clinical cohorts. Evidence strength: Preliminary to modest; small RCT data are positive but large-scale trials are lacking.
5.4 Tart Cherry (Prunus cerasus)
Tart cherry is not a traditional herbal medicine in the classical sense, but it has emerged as a food-based source of phytochemicals with sleep-relevant activity, including melatonin and anthocyanins.
Scientific evidence: A pilot study investigated the effects of tart cherry juice on sleep quality and insomnia severity in 15 older adults with chronic insomnia. The participants consumed tart cherry juice for 2 weeks. The study reported significant improvements in sleep quality, sleep latency, and insomnia severity in the tart cherry group compared to baseline. The authors suggested that the high melatonin content of tart cherries may be responsible for their sleep-promoting effects. In a 2025 systematic review of seven interventional studies, three reported significant improvements in sleep indicators such as sleep duration, sleep efficiency, or sleep onset time, and three also reported an increase in melatonin levels after tart cherry consumption. However, there were large differences in dose, duration of intervention, and characteristics of the participating populations. Although tart cherry consumption may be effective in improving sleep quality, reducing inflammation, and increasing antioxidant capacity, the available evidence is still limited and heterogeneous.
Evidence strength: Preliminary; supportive but small trials; high-quality large RCTs are needed to confirm efficacy and clarify dose-response.
5.5 Kiwifruit (Actinidia deliciosa)
Kiwifruit has received research interest because of its serotonin precursor content, antioxidant profile, and folate content. The current body of literature converges to suggest that kiwifruit subjectively and objectively improves several sleep-related parameters and outcomes in young, older, and clinical cohorts. Published human studies have been small; evidence is preliminary.
6. Dietary and Macronutrient Factors
6.1 Overall Diet Quality
Proper nutrition involves providing all of the necessary nutrients in order to maintain health and wellbeing. The foods that people consume can not only influence their wakefulness during the day, but also their quality of sleep. Sleep is not only influenced by the energy efficiency of the diet, but also by the content of macronutrients. Experimental data indicate that provision of specific foods rich in tryptophan or melatonin can improve sleep quality. Whole diets rich in fruits, vegetables, legumes, and other sources of dietary tryptophan and melatonin have been shown to predict favorable sleep outcomes.
Key focus areas in nutritional research include sleep-supportive nutrients, dietary patterns such as the Mediterranean, ketogenic, and plant-based diets, chrononutrition, and gut-brain axis modulation. Evidence supports the role of specific nutrients such as magnesium, tryptophan, and omega-3 fatty acids, as well as dietary patterns rich in anti-inflammatory and antioxidant compounds, in improving sleep outcomes.
6.2 Tryptophan-Rich Foods
Strategic dietary intake of tryptophan-rich foods such as milk, eggs, cheese, poultry, and fish will enhance serum tryptophan availability, thereby potentiating melatonin biosynthesis and subsequent sleep optimization. Milk is widely considered a sleep-promoting food in many cultures worldwide. Children are often given milk with turmeric before bedtime in certain Eastern cultures. Cow milk has high levels of tryptophan and is conducive to sleep.
6.3 Saturated Fat and Dietary Fat Composition
Total sleep time as measured by actigraphy was negatively associated with intake of total fat and saturated fat. From limited studies, consumption of saturated fatty acids appears to deteriorate sleeping wellness. This is also true if diabetes is induced due to the long-term consumption of saturated fatty acids, as diabetes is often associated with sleeping problems.
7. Stimulants and Other Dietary Factors
7.1 Caffeine
Caffeine has long been associated with sleep disorders. Evidence has grown indicating the stimulating effect of caffeine, and the extent to which regular users may merely be restoring normal functioning after abstinence from caffeine. Caffeine interrupts sleep, with sleep hygiene instructions calling for stopping caffeine consumption before bed. However, caffeine response at bedtime is variable, and withdrawal may confuse studies.
7.2 Alcohol
Alcohol misuse impairs sleep quality and circadian rhythms. Substances such as alcohol, nicotine, excess caffeine, and cannabis negatively affect the quality of sleep. They cause, among other things, an increase in the waking time after falling asleep. While alcohol is commonly believed to act as a sedative, research indicates it disrupts sleep architecture, particularly suppressing REM sleep in the second half of the night.
7.3 General Dietary Pattern Considerations
Proper nutrition that is rich in tryptophan, vitamin D, and gamma-aminobutyric acid can improve the quality of sleep. By using foods that are rich in these substances, the effectiveness and the actual sleep time are improved. Both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene; emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes.
8. Physical Activity and Lifestyle Factors
Regular physical activity has several health benefits, including improved sleep quality and symptoms of sleep disorders. Moderate-intensity exercise can improve sleep quality in insomnia patients. Patients with insomnia who exercised for 30 minutes three times per week for eight weeks experienced improved sleep quality. Additionally, moderate-intensity aerobic exercise improves sleep among patients with insomnia.
A systematic review revealed that evening exercise may positively affect sleep, but vigorous exercise might impair sleep-onset latency and total sleep time. The relationship between physical activity intensity and sleep quality is therefore nuanced and warrants context-specific consideration.
Sleep reduces energy consumption, as the basic metabolic rate decreases, partly because it reduces body temperature. Light exposure, consistent sleep-wake schedules, management of psychological stress, and minimization of artificial light at night are also recognised as important lifestyle modulators of sleep quality in the literature, operating primarily through the circadian system.
9. Evidence Summary
- Melatonin: Most consistent evidence base among natural sleep-related compounds; multiple meta-analyses of RCTs support reductions in sleep onset latency and improvements in total sleep time, particularly for circadian disruption and secondary sleep disorders. GRADE-rated evidence is characterised as weak to moderate.
- Magnesium: Growing evidence from observational studies and RCTs supporting associations with sleep quality; clinical trial data are promising but heterogeneous. Evidence is characterised as preliminary to moderate.
- Tryptophan/dietary precursors: Mechanistic and epidemiological evidence is strong; dedicated supplementation trial evidence is more limited but directionally positive.
- Omega-3 fatty acids: Observational and some interventional evidence is supportive; clinical trial data are still limited.
- Valerian root: Long traditional history; multiple systematic reviews conclude clinical evidence is inconclusive and inconsistent. The NIH ODS characterises the evidence as inconclusive.
- Ashwagandha: Preliminary positive RCT data, primarily through stress and cortisol pathways; further independent replication is needed.
- Tart cherry, kiwifruit, chamomile/apigenin: Early-stage evidence is supportive but limited in scope and scale; larger trials are required.
- L-theanine, glycine: Promising mechanistic rationale and preliminary human data; evidence base is nascent.
- Caffeine and alcohol: Consistent evidence of detrimental effects on sleep architecture; widely replicated across multiple study designs.
- Physical activity: Moderate-intensity exercise has a well-supported, positive association with sleep quality across multiple systematic reviews.
References
- Harvey AG, Stinson K, Whitaker KL, Moskovitz D, Virk H. The Subjective Meaning of Sleep Quality: A Comparison of Individuals with and without Insomnia. Sleep. 2008. PMC2276747.
- Kaczmarek J, et al. Sleep Quality: A Narrative Review on Nutrition, Stimulants, and Physical Activity as Important Factors. Nutrients. 2022. PMC9103473.
- Ohayon M, et al. Sleep quality: An evolutionary concept analysis. Nursing Forum. 2021. PubMed 34610163.
- Brain signature of sleep quality. PMC12515592.
- Phenotypic, Genetic and Environmental Architecture of the Components of Sleep Quality. PMC9463263.
- Reddy S, Reddy V, Sharma S. Physiology, Circadian Rhythm. StatPearls. NCBI Bookshelf. 2023.
- Circadian clock genes and insomnia. Annals of Medicine. 2025.
- Normal sleep and circadian rhythms: Neurobiologic mechanisms. Jefferson Digital Commons.
- McEwen BS, Karatsoreos IN. Sleep Deprivation and Circadian Disruption: Stress, Allostasis, and Allostatic Load. PMC8935364.
- Lane JM, et al. Genetics of circadian rhythms and sleep in human health. Nature Reviews Genetics. 2023.
- Pourmoradian S, et al. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. PubMed 33417003.
- Auger RR, et al. The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. PMC4273450.
- Bruni O, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2022.
- Iyer S, et al. Exogenous Melatonin and Sleep Quality: A Scoping Review of Systematic Reviews. Journal of Clinical Pharmacology. 2026.
- The Mechanisms of Magnesium in Sleep Disorders. PMC12535714.
- Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. PMC12412596.
- Arab A, et al. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. PubMed 33865376.
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial. PMC11381753.
- Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. Nutrition Reviews. 2025. PMC13075487.
- Shinjyo N, Waddell G, Green J. Valerian Root in Treating Sleep Problems and Associated Disorders—A Systematic Review and Meta-Analysis. PMC7585905.
- NIH Office of Dietary Supplements. Valerian Fact Sheet for Health Professionals.
- Kelgane SB, et al. Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep. PMC7096075.
- Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults. PMC8632422.
- Herbal and Natural Supplements for Improving Sleep: A Literature Review. PMC11321869.
- Nutritional Elements in Sleep. PMC9859770.
- Diet Composition and Objectively Assessed Sleep Quality: A Narrative Review. PMC9124688.
- Sleep and Diet: Mounting Evidence of a Cyclical Relationship. PMC8511346.
- The Effects of Dietary Nutrition on Sleep and Sleep Disorders. PMC7334763.
- Dietary Supplement Interventions and Sleep Quality Improvement: A Systematic Review and Meta-Analysis. Nutrients. 2025.
- Current Evidence on Common Dietary Supplements for Sleep Quality. PMC11082867.
- The Effect of Tart Cherry on Sleep Quality and Sleep Disorders: A Systematic Review. PMC12438961.
- The Effect of Physical Activity on Sleep Quality and Sleep Disorder: A Systematic Review. PMC10503965.
- The effect of nutrition and physical activity on sleep quality among adults: a scoping review. Sleep Science and Practice. 2023.
- Duquet L, et al. The Impact of Physical Activity on Sleep in Alcohol Users: A Systematic Review. PMC12231046.
- Nutritional Interventions for Enhancing Sleep Quality: The Role of Diet and Key Nutrients in Regulating Sleep Patterns and Disorders. PMC12678061.
- Valerenic Acid and Pinoresinol as Positive Allosteric Modulators: Unlocking the Sleep-Promoting Potential of Valerian Extract Ze 911. PMC12155840.
Natural Remedies
Ingredients
- 5-HTP (5-hydroxytryptophan)Scientific
5-HTP is the direct metabolic precursor to serotonin and melatonin, produced from dietary tryptophan via tryptophan hydroxylase. RCTs demonstrate it improves sleep quality components, particularly in poor sleepers and those with sleep disorders. A 2024 12-week RCT in older adults (n=30; 100 mg/day) found significant subjective sleep quality improvement in poor sleepers via PSQI. A crossover RCT in Parkinson's disease patients found 50 mg/day improved overall sleep stability and REM sleep.
- alpha D-ribofuranoseScientific
In the 2006 (n=41) and 2012 (n=257) open-label CFS/FMS clinical studies, 'sleep' was one of the five VAS domains showing statistically significant improvement with 15 g/day D-ribose. The 2006 pilot reported a ~29% improvement in sleep quality. These findings are limited by open-label, uncontrolled designs.
- apigeninScientific
Apigenin is the principal sedative and anxiolytic flavonoid in chamomile and passionflower, acting as a competitive partial agonist at benzodiazepine-binding sites on GABA-A receptors. It reduces sleep latency and increases pentobarbital-induced sleep in preclinical models. Clinical evidence is primarily indirect through chamomile RCTs. Used traditionally as the active pharmacological basis of chamomile's sleep and anxiety effects.
- ashwagandhaScientific
Ashwagandha (Withania somnifera) root extract has significant scientific evidence for improving sleep quality. A 2021 systematic review and meta-analysis of 5 RCTs (n=400) found a small but significant effect on overall sleep (SMD −0.59; 95% CI −0.75 to −0.42), with greater effects at doses ≥600 mg/day and treatment ≥8 weeks. It modulates GABA-A receptors (ρ1 subtype) and histamine H3 receptors. In Ayurvedic medicine, it has been used for centuries as a nervine tonic.
- bacopaScientific
A randomized, double-blind, placebo-controlled human trial examined Bacopa's effects on sleep quality in adults with self-reported poor sleep. While the primary insomnia scale outcome was not met, secondary outcomes showed improvements in emotional wellbeing and health-related quality of life. A second RCT on stress management also assessed sleep-related outcomes.
- bifidobacterium longumScientific
Two distinct RCTs demonstrate B. longum improves sleep quality. B. longum 1714 (8-week, double-blind RCT, n=89) significantly improved the PSQI sleep quality component and reduced daytime dysfunction due to sleepiness. B. longum NCC3001 (6-week RCT, n=45) also improved subjective sleep quality scores versus placebo.
- biota seedScientific
Multiple preclinical studies confirm that biota seed extracts improve sleep quality parameters—including shortened onset and prolonged duration—through serotonergic and GABAergic mechanisms. Semen Platycladi is described in pharmacological literature as having 'sleep improvement' as a confirmed pharmacological effect alongside antioxidant and anti-inflammatory activity. Human evidence is absent.
- black cohoshScientific
Black cohosh has demonstrated improvements in subjective and objective sleep quality in perimenopausal and postmenopausal women. Polysomnographic studies have shown increased sleep efficiency and reduced wakefulness. Evidence outside the menopausal context is absent.
- black spruceScientific
A published study in the Journal of Essential Oil Bearing Plants (2023) investigated Picea mariana essential oil in a mouse insomnia model, measuring sleep latency, duration, and neurochemical markers. PMEO showed hypnotic effects associated with modulation of 5-HT1A and GABA-A receptor pathways. This is preclinical evidence only.
- california poppyScientific
California poppy has been evaluated for overall sleep quality improvement in observational human research. The Abdellah et al. (2019) study showed significant reductions in insomnia severity index scores over 4 weeks with an E. californica/valerian combination. The EMA recognizes the herb as a traditional medicine for minor sleep disorders, and Health Canada has authorized a standardized product as a mild hypnotic. Preclinical neurophysiological studies in rodents document improved sleep architecture.
- chamomileScientific
Chamomile (Matricaria chamomilla) has been used in traditional European and Middle Eastern medicine for thousands of years as a calming, sleep-promoting herb. Its flavonoid apigenin binds benzodiazepine receptor sites on GABA-A receptors, explaining its sedative and anxiolytic effects. Clinical evidence includes a systematic review and meta-analysis indicating chamomile is efficacious and safe for improving sleep quality and generalized anxiety. A 2016 RCT in postpartum women found chamomile significantly improved sleep quality vs. control.
- cherryScientific
Human RCTs consistently show that tart cherry juice improves objective and subjective sleep quality, increases urinary melatonin metabolites, and enhances sleep efficiency. Evidence spans healthy adults, older insomniacs, and athletes. Effects are attributed to melatonin content, tryptophan availability, and anti-inflammatory anthocyanins.
- D-riboseScientific
Sleep was a pre-specified VAS outcome in two open-label clinical trials of D-ribose in CFS/fibromyalgia patients, both reporting statistically significant improvements. The multicenter study of 257 patients documented a 29.3% improvement in sleep quality. No dedicated sleep-focused RCT exists, so evidence remains limited in rigor.
- daidzinScientific
Animal studies show daidzin significantly reduces sleep latency and prolongs sleep duration in mice via GABAA receptor interaction, with synergistic effects with diazepam. Molecular docking confirms binding to GABAA α1 and β2 subunits. Evidence is exclusively preclinical.
- fu lingScientific
Clinical human evidence supports Poria cocos improving overall sleep quality. An 800 mg/night clinical trial (n=21, polysomnography) showed significant increases in total sleep duration and reduced arousal. A separate 4-week RCT (n=70) reported a 59.94% improvement in PSQI scores. A meta-analysis of 13 RCTs (922 patients) also found sleep quality improvement in P. cocos-based formulas.
- GABA (gamma aminobutyric acid)Scientific
GABA is the principal inhibitory neurotransmitter in the CNS and plays a central role in sleep regulation by suppressing wake-promoting systems. Oral GABA has been explored as a sleep supplement, with some evidence suggesting it can reduce sleep latency and improve NREM sleep, particularly in combination with L-theanine. A 2024 double-blind RCT combining GABA with Poria cocos and Ziziphus spinosa significantly improved PSQI scores. Evidence for oral GABA alone remains limited due to uncertain CNS bioavailability.
- ganodermaScientific
Multiple preclinical studies and a neurasthenia RCT support Ganoderma lucidum's ability to improve overall sleep quality. Mechanisms include GABAergic potentiation, serotonin pathway upregulation via gut microbiota, and suppression of neuroinflammation. The evidence is strongest in preclinical models but directionally supported by clinical findings in disease-affected populations.
- gardenia jasminoidesScientific
A double-blind, placebo-controlled crossover human trial showed that crocetin from Gardenia jasminoides reduced nighttime wakening episodes (objective actigraph, p=0.025) in men with mild sleep complaints over 2 weeks. Preclinical studies additionally show modulation of gut microbiota by GJE correlates with improved sleep quality metrics in rodents.
- gastrodiaScientific
GE and its bioactives improve overall sleep quality parameters in animal models, including non-REM sleep, sleep architecture, and sleep-related neurochemistry. The Pharmacopoeia of the PRC includes GE preparations for insomnia. Fermented GE shows sleep-quality improvement in preclinical research.
- glycineScientific
Multiple human RCTs and a systematic review across 42 RCTs demonstrate that 3 g glycine taken 30 minutes before bedtime significantly reduces sleep latency, improves subjective sleep quality, and yields objective polysomnographic improvements. A follow-on trial showed it also attenuates next-day cognitive impairment after partial sleep restriction. The mechanism involves facilitation of core body temperature drop and NMDA receptor modulation in the suprachiasmatic nucleus.
- goji berryScientific
A 2008 human study using standardized goji berry juice found improved sleep quality among participants vs. controls. A meta-analysis pooling data from four RCTs using standardized goji juice observed significant improvements in sleep quality. Animal studies show LBP has neuroprotective effects on hippocampal function disrupted by sleep-apnea-related hypoxia.
- ho woodScientific
Linalool, the dominant constituent of ho wood (~95–99%), has demonstrated sedative and hypnotic effects in multiple animal studies, including prolonging sleep duration and shortening sleep latency. Ho wood is used in aromatherapy as a sleep aid via diffusion before bedtime.
- honeyScientific
Honey has shown improvement in nocturnal sleep quality in children with cough due to upper respiratory infections across multiple RCTs. The 2018 Cochrane review confirmed honey is more effective than no treatment and placebo for improving children's sleep impacted by cough. Limited adult sleep evidence exists beyond this pediatric cough context.
- honokiolScientific
Honokiol is a neolignan from Magnolia officinalis bark that potentiates GABA-A receptor activity and has demonstrated sleep-promoting effects in preclinical models, promoting both NREM and REM sleep. It is the principal bioactive constituent responsible for the traditional sleep and anxiolytic effects of magnolia bark (Hou Po in TCM). Animal studies confirm dose-dependent sleep induction via GABAergic mechanisms, with in vitro evidence of nanomolar-range GABA-A receptor potentiation.
- hopsScientific
Hops (Humulus lupulus) strobiles have been used traditionally in European folk medicine as a sedative, often stuffed into pillows or combined with valerian for insomnia. The active constituent 2-methyl-3-buten-2-ol (formed from hop bitter acids) and 8-prenylnaringenin modulate GABA-A receptors. A 2024 review (PMC) found hops among the strongest herbal evidence for sleep quality and insomnia alongside valerian and melatonin. RCTs typically test hops in combination with valerian.
- jujubeScientific
Jujube seed (Ziziphus jujuba var. spinosa / Zizyphus spinosa, known as Suanzaoren in TCM) has over 2,000 years of documented use in East Asian traditional medicine for insomnia and anxiety. Its bioactive jujubosides A and B and spinosin modulate GABA-A and serotonin 5-HT1A receptors, producing sedative and hypnotic effects. RCT evidence in postmenopausal women with poor sleep and a 2024 clinical trial combining jujube with GABA and Poria cocos confirmed significant PSQI improvements.
- jujubosidesScientific
Jujubosides are the principal triterpenoid saponins of jujube seed (Ziziphus jujuba var. spinosa) responsible for its sedative and sleep-promoting pharmacology. They modulate GABA-A receptors and regulate multiple neurochemical pathways. Jujuboside A is the most studied compound and has demonstrated sedative effects, reduction of locomotor activity, and increased sleep duration in rodent models. Traditional use underpins their use in TCM sleep formulas; clinical data come from jujube seed RCTs.
- kannaScientific
A 9-week RCT found subjective sleep quality improvements in middle-aged adults on 25 mg/day Zembrin. Traditional use included hypnotic applications. Mechanistically, melatonin receptor activation, serotonin modulation, and calming effects may all contribute to improved sleep quality.
- kavaScientific
Kava (Piper methysticum) root extract has well-documented evidence from RCTs and meta-analyses for reducing anxiety-related insomnia. Kavalactones modulate GABA-A receptors and block norepinephrine reuptake, producing anxiolytic and sedative effects. A Cochrane review and meta-analysis of RCTs confirmed significant efficacy for anxiety with secondary benefits to sleep. It is used traditionally in Pacific Island cultures as a ceremonial and relaxation beverage, and was widely used in European phytomedicine before hepatotoxicity concerns led to some regulatory restrictions.
- L-glycineScientific
Glycine is a non-essential amino acid that subjectively and objectively improves sleep quality in individuals with insomnia or restricted sleep. Human RCTs at 3 g before bedtime found improved PSQI scores, reduced sleep latency, increased slow-wave sleep, and reduced daytime fatigue. The mechanism involves NMDA receptor modulation in the suprachiasmatic nucleus causing peripheral vasodilation and body temperature lowering, which promotes sleep onset.
- L-ornithineScientific
A randomized, double-blind, placebo-controlled trial in 52 healthy Japanese workers found that 400 mg/day of L-ornithine for 8 weeks significantly improved perceived sleep quality on the Athens Insomnia Scale and the OSA-MA sleep inventory. Serum cortisol and the cortisol/DHEA-S ratio were also significantly reduced in the L-ornithine group. A separate crossover RCT confirmed improved sleep scores in subjects taking 400 mg L-ornithine after alcohol consumption. The proposed mechanism involves L-ornithine-driven increases in striatal serotonin metabolite (5-HIAA), which promotes nocturnal melatonin synthesis.
- L-serineScientific
Japanese clinical research found that oral L-serine taken 30 minutes before bed significantly improved both sleep initiation and sleep maintenance scores in adults who were dissatisfied with their sleep quality. The proposed mechanism involves L-serine's role as a precursor in the tryptophan-serotonin-melatonin pathway and its modulation of NMDA receptor activity.
- L-theanineScientific
L-theanine, a non-proteinogenic amino acid found in green tea, promotes relaxation and improves sleep quality by enhancing GABA, serotonin, and dopamine levels and reducing glutamatergic excitatory activity. Multiple clinical studies report improvements in subjective sleep quality, NREM sleep, and reduced sleep latency. A 2025 systematic review in Nutritional Neuroscience confirmed benefits across dietary supplementation trials. Typical effective dose is 100–400 mg at bedtime.
- L-tryptophanScientific
L-Tryptophan is the dietary amino acid precursor to serotonin and melatonin, and its supplementation supports sleep quality by increasing serotonin synthesis and subsequent nocturnal melatonin production. Clinical evidence includes improvements in sleep onset latency and sleep duration, particularly in individuals with insomnia. A 2024 RCT in healthy adults with sleep problems found tryptophan combined with ashwagandha significantly improved VAS sleep quality vs. control. Typical effective dose is 0.5–2 g before bedtime.
- lactobacillus gasseriScientific
L. gasseri CP2305 has demonstrated improvements in sleep quality in at least two RCTs in humans under chronic stress conditions. A 4-week crossover RCT in medical students showed significant improvement in global sleep quality (Pittsburgh Sleep Quality Index), and a 24-week parallel-group RCT confirmed reductions in sleep disturbance. Improvements in sleep are linked to HPA axis modulation and gut-brain axis signaling.
- lavenderScientific
Lavender (Lavandula angustifolia) essential oil and oral preparations have traditional and growing clinical evidence for improving sleep quality. Orally, linalool and linalyl acetate modulate GABA-A receptors. A 2021 systematic review found lavender preparations (oral Silexan 80 mg capsules in particular) significantly improved sleep in anxiety-related insomnia in multiple RCTs. Multiple OTC RCTs and a 2025 scoping review list lavender among products with significant sleep benefits.
- lemon balmScientific
Lemon balm (Melissa officinalis) is a traditional European nervine herb used since antiquity for anxiety, restlessness, and sleep difficulties. Its rosmarinic acid and flavonoids inhibit GABA-transaminase, increasing synaptic GABA availability and improving sleep quality and anxiety. Clinical RCTs demonstrate improved PSQI scores and reduced insomnia severity, often in combination with valerian. A 2025 OTC sleep RCT scoping review identified lemon balm combinations as having significant sleep benefits.
- lilyScientific
Lily bulb demonstrates sedative and hypnotic properties in preclinical pharmacological studies, consistent with its Pharmacopoeia-listed indication for insomnia. Multi-herb formulas containing lily bulb show evidence of improved sleep quality via neurotransmitter modulation. Lily bulb amino acids and alkaloids support mood and sleep pathways. Evidence is primarily preclinical and formula-based.
- lion's maneScientific
An 8-week RCT in 77 overweight adults found Lion's Mane supplementation improved sleep disorders by 39.1% versus baseline. A 2026 double-blind RCT (n=109) found significantly improved subjective sleep quality and morning restedness versus placebo. Mechanisms may include NGF/BDNF support and gut-microbiome-mediated serotonin regulation.
- lotus seedScientific
A clinical pilot study with Nelumbo nucifera seed extract (combined with Rhodiola rosea) significantly improved both ISI and PSQI total scores in adults with subthreshold insomnia. Animal research robustly documents GABAergic mechanisms underlying lotus seed's sleep-promoting effects.
- magnesiumScientific
Magnesium is an essential mineral that modulates NMDA receptor activity and GABA-A receptor function, supporting both CNS inhibitory tone and melatonin production. A systematic review and meta-analysis of RCTs found magnesium supplementation reduced sleep onset latency by 17.36 min (p=0.0006) vs. placebo in older adults with insomnia. A 2024 RCT (n=155; 250 mg elemental magnesium bisglycinate) confirmed improvements in insomnia severity in healthy adults with poor sleep. Evidence quality is rated low-to-moderate, with larger RCTs needed.
- magnoliaScientific
Magnolia bark (Magnolia officinalis) contains honokiol and magnolol, which modulate GABA-A receptors to promote REM and non-REM sleep. In vitro binding studies and animal models confirm GABA-A receptor potentiation. Magnolia bark has traditional use in Chinese and Japanese medicine (Hou Po) for anxiety, insomnia, and digestive complaints. Clinical combination products including magnolia have shown improvements in menopausal sleep symptoms in human studies.
- melatoninScientific
Melatonin is the primary endogenous regulator of the sleep-wake cycle, produced by the pineal gland in response to darkness. Multiple systematic reviews and meta-analyses of RCTs confirm it reduces sleep onset latency, increases total sleep time, and improves subjective sleep quality as measured by the PSQI. Prolonged-release melatonin (2 mg) is approved in the EU for primary insomnia in adults over 55. A 2021 meta-analysis (PubMed PMID 33417003) found a significant effect on PSQI score (WMD −1.24; 95% CI −1.77 to −0.71).
- myrobalanScientific
The 2025 RCT of a TC + Boswellia combination (300 mg, 120 days, n=100) demonstrated significant improvement in sleep quality as measured by the Athens Insomnia Scale versus placebo in adults with subjective memory and cognitive complaints.
- NMN (β-nicotinamide mononucleotide)Scientific
A 12-week double-blind RCT in 108 older Japanese adults found NMN (250 mg/day) taken in the afternoon (NMN_PM group) showed the largest effect sizes for improved lower limb function and reduced drowsiness. However, no statistically significant between-group interaction was found for PSQI sleep quality scores overall.
- oriental arborvitaeScientific
Beyond sleep onset, Semen Platycladi preparations have been shown to prolong total sleep duration in rodent insomnia models, indicating improved overall sleep quality. Neurotransmitter modulation (5-HT and GABA) is the identified mechanism. This is consistent with the herb's 2,000-year TCM use as a sedative-hypnotic.
- passionflowerScientific
Passionflower (Passiflora incarnata) is used traditionally in European and North American herbalism for insomnia and anxiety. It increases GABA levels in the brain via GABA-A receptor modulation. A double-blind RCT (Phytotherapy Research) found passionflower tea significantly improved subjective sleep quality vs. placebo over one week using polysomnographic measures. It is among a small number of herbal preparations with positive outcomes in sleep-focused RCTs.
- polygalaScientific
Polygalasaponins and polygala root extract improve multiple measures of sleep quality in preclinical models—reducing sleep latency, extending sleep duration, and normalizing GABA/serotonin ratios—providing a mechanistic basis for TCM's historical use of Yuan Zhi for insomnia and restless sleep.
- pregnenoloneScientific
Pregnenolone sulfate infusions significantly increase paradoxical (REM) sleep in animal models via ACh modulation. Lower allopregnanolone levels (a pregnenolone metabolite) correlate inversely with sleep disturbance in clinical populations. An ongoing VA-sponsored trial lists sleep as a primary target outcome.
- progesteroneScientific
Progesterone improves overall sleep quality in peri- and postmenopausal women by increasing slow-wave sleep, reducing nighttime awakenings, and potentially improving sleep-disordered breathing. Multiple RCTs measuring Pittsburgh Sleep Quality Index (PSQI) scores show significant improvement with oral micronized progesterone.
- pumpkinScientific
Pumpkin seeds are one of the richer food sources of tryptophan, the essential amino acid that serves as the biosynthetic precursor to serotonin and melatonin—key regulators of sleep onset and sleep quality. Magnesium, also abundant in seeds, supports neuromuscular relaxation. The tryptophan-serotonin-melatonin pathway is mechanistically well-established.
- pyrroloquinoline disodium saltScientific
An open-label clinical trial (n=17) of PQQ disodium salt at 20 mg/day for 8 weeks found significant improvements in sleep onset and maintenance, sleep duration, and sleepiness at awakening as measured by validated sleep inventories. Mood and fatigue scores also improved.
- reishi mushroomScientific
Multiple human studies support improvements in subjective sleep quality with reishi supplementation. The 2026 multi-mushroom RCT showed significant PSQI improvement. The 2026 SLEEP RCT found reishi outperformed melatonin on ISI. Small clinical studies in fatigue and stress populations also report improved sleep quality. TCM records reishi as a primary insomnia remedy for over 2,000 years.
- reloraScientific
Sleep quality is a direct endpoint in two Relora® clinical studies. Kalman (FASEB 2006) found Relora reduced sleep latency by twice as much as placebo (11 min vs. 5 min, p=0.012). An early open-label pilot found 74% of participants experienced more restful sleep on Relora. Mechanistically, honokiol's GABA-A and benzodiazepine-site activity promotes NREM sleep without heavy sedation.
- rhodiolaScientific
A 2024 PMC human pilot study found that a combination of Rhodiola rosea and Nelumbo nucifera extracts (750 mg/day, two weeks) significantly improved ISI and PSQI scores in adults with subthreshold insomnia. Student studies also reported improved sleep patterns following Rhodiola supplementation during high-stress exam periods. Evidence is preliminary, deriving from small or combination-product trials.
- rosemaryScientific
A randomized clinical trial in university students found that 500 mg of rosemary taken orally twice daily for one month significantly improved sleep quality scores alongside anxiety and memory benefits. Aromatherapy with rosemary-lemon oil also improved sleep quality in elderly adults in a pre/post study.
- rosmarinic acidScientific
RA-standardized Melissa officinalis (lemon balm) extracts have improved sleep quality in clinical populations including postmenopausal women (combined with valerian) and cardiac patients. RA's sleep-promoting mechanism involves GABA transaminase inhibition, prolonging GABAergic calming neurotransmission. A 2017 RCT with rosemary (containing RA) also reported sleep quality improvements in university students.
- saffronScientific
Saffron (Crocus sativus) and its bioactive crocetin have evidence from multiple RCTs for improving sleep quality in adults with mild-to-moderate sleep disorders. A 6-week RCT (n=66; 15.5 mg/day) using actigraphy and PSQI found significant improvements in sleep parameters vs. placebo. A meta-analysis of 8 clinical trials reported improved sleep quality and minimal adverse effects. Crocin and safranal modulate serotonin and GABA-A pathways.
- safranalScientific
Safranal is a principal volatile constituent of saffron (Crocus sativus) responsible for its characteristic aroma and a key pharmacological mediator of saffron's sleep-promoting and anxiolytic effects. It acts as a GABA-A receptor agonist and inhibits serotonin reuptake. Animal studies confirm hypnotic properties, and safranal-containing saffron extracts have demonstrated sleep improvement in human RCTs. Safranal is part of the active phytochemical basis for saffron's clinical sleep evidence.
- sceletiumScientific
The Chiu et al. (2014) proof-of-concept RCT found positive changes in sleep alongside cognitive improvements in healthy older adults receiving 25 mg Zembrin® daily for three weeks. Traditional use of sceletium as a sedative/soporific in children is also well-documented ethnobotanically.
- schisandraScientific
Schisandra has been used in TCM for centuries in formulas specifically targeting sleep quality and dream-disturbed sleep. A 2021 PubMed rodent study demonstrated schisandra promoted NREM sleep and reduced cardiovascular dysfunction associated with insomnia via HPA axis modulation. Small human studies in the Soviet adaptogen literature report improved sleep quality as part of broader anti-stress effects.
- schisandrinsScientific
Schisandrin B improves multiple sleep quality indices in rodent models by elevating GABA and reducing glutamate levels in the CNS, upregulating GABA-A receptors. Traditional TCM use for dream-disturbed sleep and insomnia is well documented. Human RCTs for sleep quality as a primary outcome have not been published for isolated schisandrins.
- sclerotiumScientific
Clinical and preclinical evidence supports Poria cocos sclerotium improving sleep quality, increasing total sleep duration, reducing sleep latency, and extending NREM sleep via GABA-A receptor activation. A small human trial (n=21) with polysomnography showed statistically significant improvements.
- silk treeScientific
Multiple preclinical studies show A. julibrissin prolongs sleep duration and protects sleep-dependent memory consolidation. It is included in multi-herb formulae that have been assessed with the Pittsburgh Sleep Quality Index (PSQI) in clinical studies. TCM use for restorative sleep is extensive.
- skullcapScientific
A 2025 randomized, double-blind, placebo-controlled crossover RCT (n=66) of 400 mg/day S. lateriflora extract (BlueCALM) for 56 days in adults with primary insomnia showed progressive improvement in Pittsburgh Sleep Quality Index scores in the skullcap group versus deterioration in the placebo group. Traditional use as a sedative herb also has centuries of support.
- st. john's wortScientific
A double-blind polysomnographic study found SJW significantly increased slow-wave (deep) sleep compared to placebo in healthy volunteers. Sleep disturbance is also a core symptom of depression, in which SJW is well-evidenced. Evidence for sleep quality improvements independent of depression is limited but includes objective polysomnographic data.
- threonic acidScientific
Multiple RCTs have tested MgT (containing threonic acid as ligand) specifically for sleep quality. A 2024 RCT in 80 adults with sleep problems found significant improvements in insomnia severity and restorative sleep after 21 days. A 2026 RCT in 100 adults confirmed improvements in sleep-related impairment.
- tributyrinScientific
Oral tributyrin administration robustly increases non-rapid eye movement sleep (NREM) in rodents, with one study reporting a 47–50% increase in NREM duration over 4 hours post-dosing. The mechanism involves hepatoportal butyrate-sensitive sensory neurons. A human RCT using butyrate supplementation in ulcerative colitis patients also reported improved sleep quality.
- valerian rootScientific
Valerian root (Valeriana officinalis) has been used in European traditional medicine for centuries as a sedative and sleep aid. A 2006 meta-analysis in the American Journal of Medicine of 16 RCTs (n=1,093) found a statistically significant benefit for improved sleep quality (relative risk 1.8; 95% CI 1.2–2.9). Its active constituents valerenic acid and valepotriates modulate GABA-A receptors and inhibit GABA catabolism. Evidence quality is moderate due to methodological heterogeneity across trials.
- wasabiScientific
In an open-label study of 20 healthy adults with daily fatigue, 4.8 mg/day of 6-MSITC for 4 weeks improved self-reported sleep quality compared to baseline. In the ME/CFS trial, a trend toward improved PSQI scores was observed (1 vs. 3 patients meeting normal sleep threshold after treatment), though formal significance was not reached. Evidence is early-stage due to open-label designs.
- waterhyssopScientific
Bacopa monnieri supplementation has been associated with improved sleep quality in recent RCTs. A 2026 RCT measuring PSQI scores found improvements in sleep quality over 84 days, and a separate 12-week trial reported improved sleep as a secondary outcome.
- amberTraditional
Amber (Hu Po) is a classical TCM herb for sleep disturbance, used for dream-disturbed, restless sleep with underlying anxiety or palpitations. Animal studies show sedative effects of succinic acid. No human trials exist for sleep quality specifically.
- anemarrhena asphodeloidesTraditional
Anemarrhena is classified as sedative in traditional pharmacopeias and is traditionally prescribed for sleep disturbances, night sweats, and restlessness. Its use for 'insomnia with dysphoria' is documented in classical TCM texts, and preclinical evidence suggests mild CNS-modulating activity.
- asparagusTraditional
A. racemosus (shatavari) is traditionally used in Ayurveda as a nervine tonic with sedative properties. Insomnia and sleep disturbances are among the menopausal symptoms improved in shatavari RCTs. Preclinical evidence shows asparagus modulates GABAergic and monoaminergic neurotransmission relevant to sleep regulation.
- dogwoodTraditional
Jamaican dogwood has documented traditional use to improve sleep quality, particularly when disrupted by pain, nervous tension, or anxiety. Rodent studies support CNS depressant activity. It is recognized in the British Herbal Pharmacopoeia and PDR for Herbal Medicines for sleep-related indications.
- hawthornTraditional
Hawthorn is traditionally used to improve sleep quality, particularly when sleep disturbance is linked to nervous tension or palpitations. Animal CNS depressant data support the traditional rationale. Available human data involve combination products without hawthorn-specific isolation of effect.
- mugwortTraditional
Mugwort has a long-standing traditional use for promoting dream vividness and overall sleep quality, attributed to thujone's GABA-A modulation and MAO-inhibiting phenolics. It appears in the European Pharmacopoeia for sleep-adjacent nervous disorders. No human RCTs have measured objective sleep outcomes.
- polygala rootTraditional
Polygala root is traditionally used in TCM for insomnia and sleep disturbance. Animal studies show that saponin fractions prolong both NREM and REM sleep and modulate key sleep neurotransmitters. Traditional documentation of sedative properties is robust and supported by mechanistic preclinical evidence.
- poppyTraditional
Improved sleep quality—depth and continuity—is a long-established traditional claim for poppy across several herbal systems. California poppy combination clinical data suggests modest improvements in sleep efficiency, but well-controlled standalone trials are lacking.
- soursopTraditional
Closely related to its documented traditional use for insomnia, soursop (particularly its leaves) is used as a sedative and nervine agent in traditional medicine across several tropical regions. Pre-clinical data on sedative alkaloid content supports biological plausibility.
- wood betonyTraditional
Wood betony is traditionally used to promote deeper, more restorative sleep, particularly when disturbed by stress and nervous tension. Its calming and mild sedative properties are the basis of this use in European herbalism. No clinical research exists.